Buy at a 40% discount to what these shares were sold to institutional investors in August 2019.
They were sold at 21 cents. This was after the anti-inflammatory and super-bug killing data was released.
Now the market is down on the company, admittedly after an own goal of sorts.
Nevertheless, the Australian acne data was convincing. This is fixable and hopefully just the wake up call the company needed.
"Buy when there's blood in the streets, even if the blood is your own."
Baron Rothschild
Buy at a 40% discount to what these shares were sold to...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
0.025(7.46%) |
Mkt cap ! $567.0M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 36.5¢ | 33.3¢ | $14.94M | 42.66M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 112268 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 276101 | 7 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| BOT (ASX) Chart |